CTQ2005 – HP2008-0015

Anti-neoplastic therapy aiming to study the features of SLN for targeting e.g. Trastuzumab to breast cancer cells, by means of functionalizing the surface of the particles (CTQ2005 – HP2008-0015) – Team Member